Drug Shortage Leaves Patients Without Immune-Disorder Treatment

  • 📰 WSJ
  • ⏱ Reading Time:
  • 14 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 63%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

A shortage of an immune-disorder treatment has forced hospitals to ration. “I understand the situation, but I’m definitely not looking forward to going back to having more pain.”

The medicine, immune globulin, contains antibodies harvested from plasma, a component of blood.

The injected product helps people with compromised immune systems fight off infections, and treats certain muscle and nerve disorders. The drug’s shortage increases the risk of infection for patients and the amount of pain they are suffering, doctors say.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

But they can have military weapons 🇺🇸

what is this, a planned shortage to jack up the price

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA backs Gilead's HIV prevention drug for certain populationFDA advisory panel on Wednesday votes in favor of Gilead's combination drug to reduce the risk of sexually acquired HIV infection in men and transgender women who have sex with men. Unfortunate name.
Source: NBCNews - 🏆 10. / 86 Read more »

FDA: Pricey Drug Approved on Manipulated DataApproval for a drug meant to treat children with a severe form of spinal muscular atrophy -- which costs over $2 million for a single treatment -- was based on manipulated data provided by the drug's maker, the FDA reports. Thx for giving tension and making me feel stupid }%** ! Whooops
Source: WebMD - 🏆 709. / 51 Read more »

FDA panel backs Gilead's HIV prevention drug Descovy, except in womenAn FDA advisory panel on Wednesday voted in favor of Gilead Sciences Inc's ... Blessed be the fruit Poor choice in business name Poor choice in headline. Women are not a tiny fraction of the world. Maybe 'but only for men' would be a better choice?
Source: Reuters - 🏆 2. / 97 Read more »

Bausch Health CEO: Big Pharma will survive US drug regulationsPharmaceuticals are 'the most cost effective way' to treat and improve health care, Bausch Health Chariman and CEO Joseph Papa says. What a relief so glad to hear LOL IFB TOYOGUAJARDO hydroxychloroquine uses https://keys-chloroquineclinique.com/
Source: CNBC - 🏆 12. / 72 Read more »